Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Formulation and Use and Manufacture Thereof

a technology of liquid pharmaceuticals and pharmaceutical formulations, applied in the direction of medical preparations, pharmaceutical delivery mechanisms, tobacco, etc., can solve the problems of not satisfying the craving, not providing for a sufficiently rapid uptake of nicotine without, and not satisfactorily fulfilling the hitherto known means and methods, etc., to achieve rapid and/or sustained and/or complete reduction of the urge to smoke or use tobacco.

Inactive Publication Date: 2007-07-19
PHARMACIA AB
View PDF35 Cites 88 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0042] Use of said product will according to the invention rapidly deliver nicotine in any form to a subject and will also provide for obtaining a quick and / or sustained and / or complete reduction of the urge to smoke or use tobacco and / or for providing a sense of smoking satisfaction without smoking resembling the sense of smoking satisfaction obtained after regular smoking or use of tobacco.

Problems solved by technology

The captioned means and methods do not satisfy the craving that certain users of tobacco experience.
Specifically these means and methods generally do not provide for a sufficiently rapid uptake of nicotine without adverse effects.
This means that none of the hitherto known means and methods satisfactorily fulfills the following well-known NRT teaching by Russel et al:

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulation and Use and Manufacture Thereof
  • Formulation and Use and Manufacture Thereof
  • Formulation and Use and Manufacture Thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0148] Manufacturing of a 1000 ml formulation with 10 mg nicotine / ml and around pH 8.5.

[0149] Mixture 1

[0150] To a beaker containing 800 ml water of 90° C. was added 0.7 g methyl para-hydroxybenzoate, acting as preservative, and 0.3 g propyl para-hydroxybenzoate, acting as preservative. The additives were dissolved during stirring for about 10 minutes. Then was added 10.45 g sodium dihydrogen phosphate, acting as buffering agent, and 0.5 g EDTA, acting as chelating agent, to the solution, which was stirred for about 5 minutes. Then the solution was cooled to 30° C. during stirring.

[0151] Mixture 2

[0152] To a beaker containing 15.9 g ethanol of room temperature, acting as solvent, was added 0.045 g peppermint oil, acting as flavoring agent. The liquid was mixed for 2 minutes.

[0153] Final Mixture

[0154] Mixture 2 was added during stirring to a beaker containing 150 ml water. Gently 10 g nicotine (base) was added to the beaker. Then Mixture 1 was added to the beaker and stirred fo...

example 2

[0155] Manufacturing of a 1000 ml formulation with 10 mg nicotine / ml and around pH 7.0.

[0156] This Example 2 differs from Example 1 only for pH. The formulation according to Example 2 contains a non-alkalizing buffering agent. This formulation was for use as a comparison in FIG. 2.

[0157] Mixture 1

[0158] To a beaker containing 800 ml water of 90° C. was added 0.7 g methyl para-hydroxybenzoate, acting as preservative, and 0.3 g propyl para-hydroxybenzoate, acting as preservative. The additives were dissolved during stirring for about 10 minutes. Then was added 10.45 g sodium dihydrogen phosphate, acting as buffering agent, and 0.5 g EDTA, acting as chelating agent, to the solution, which was stirred for about 5 minutes. Then the solution was cooled to 30° C. during stirring.

[0159] Mixture 2

[0160] To a beaker containing 15.9 g ethanol of room temperature, acting as solvent, was added 0.045 g peppermint oil, acting as flavoring agent. The liquid was mixed for 2 minutes.

[0161] Fina...

example 3

[0163] Manufacturing of a 1000 ml formulation with 10 mg nicotine / ml and around pH 6.0.

[0164] This Example 3 differs from Example 1 only for pH. The formulation according to Example 3 contains a non-alkalizing buffering agent. This formulation was for use as a comparison in FIG. 2.

[0165] Mixture 1

[0166] To a beaker containing 800 ml water of 90° C. was added 0.7 g methyl para-hydroxybenzoate, acting as preservative, and 0.3 g propyl para-hydroxybenzoate, acting as preservative. The additives were dissolved during stirring for about 10 minutes. Then was added 10.45 g sodium dihydrogen phosphate, acting as buffering agent, and 0.5 g EDTA, acting as chelating agent, to the solution, which was stirred for about 5 minutes. Then the solution was cooled to 30° C. during stirring.

[0167] Mixture 2

[0168] To a beaker containing 15.9 g ethanol of room temperature, acting as solvent, was added 0.045 g peppermint oil, acting as flavoring agent. The liquid was mixed for 2 minutes.

[0169] Fina...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

This invention relates to a liquid pharmaceutical formulation for delivering nicotine to a subject. This invention also relates to a method and a system for delivering nicotine as well as manufacturing and use of said liquid pharmaceutical formulation.

Description

CROSS REFERENCE TO RELATED PATENT APPLICATIONS [0001] The present application is a divisional of U.S. patent application Ser. No. 10 / 345,676 filed Jan. 16, 2003 which claims benefit of U.S. Patent Application Ser. No. 60 / 351,178, filed Jan. 21, 2002, each of which is explicitly incorporated herein by reference in its entirety and for all purposes.FIELD OF THE INVENTION [0002] This invention relates to a liquid pharmaceutical formulation for delivering nicotine to a subject. This invention also relates to a method and a system for delivering nicotine as well as manufacturing and use of said liquid pharmaceutical formulation. BACKGROUND OF THE INVENTION Tobacco Dependence and Reduction Thereof [0003] In recent years, with the recognition of the harmful effects of tobacco smoking, there have been numerous campaigns and programs by governmental agencies and various health groups and other interested organisations to disseminate information about the adverse health effects resulting fro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A24F47/00A61K31/465
CPCA61K31/465A61K45/06A61K9/0002
Inventor LINDELL, KATARINA E.A.BOSSON, BENGT A.BERGENGREN, GUNNAR A.SCHLUTER, ANETTE K.
Owner PHARMACIA AB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com